204 related articles for article (PubMed ID: 10589371)
1. Treatment of ocular infections with topical antibacterials.
Leeming JP
Clin Pharmacokinet; 1999 Nov; 37(5):351-60. PubMed ID: 10589371
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic considerations in the treatment of bacterial keratitis.
Callegan MC; O'Callaghan RJ; Hill JM
Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolones: place in ocular therapy.
Smith A; Pennefather PM; Kaye SB; Hart CA
Drugs; 2001; 61(6):747-61. PubMed ID: 11398907
[TBL] [Abstract][Full Text] [Related]
4. Topical ocular delivery of fluoroquinolones.
Pawar P; Katara R; Mishra S; Majumdar DK
Expert Opin Drug Deliv; 2013 May; 10(5):691-711. PubMed ID: 23419018
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
Stroman DW; Dajcs JJ; Cupp GA; Schlech BA
Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of sparfloxacin eye drop in the management of conjunctival and corneal infection.
Vyas U; Desai T; Shah C
J Indian Med Assoc; 2002 Jun; 100(6):398-9. PubMed ID: 12416674
[TBL] [Abstract][Full Text] [Related]
8. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
9. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
[TBL] [Abstract][Full Text] [Related]
10. Ocular delivery systems for topical application of anti-infective agents.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
[TBL] [Abstract][Full Text] [Related]
11. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ
Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451
[TBL] [Abstract][Full Text] [Related]
12. Safety of moxifloxacin as shown in animal and in vitro studies.
McGee DH; Holt WF; Kastner PR; Rice RL
Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S46-54. PubMed ID: 16257310
[TBL] [Abstract][Full Text] [Related]
13. Comparative review of topical ophthalmic antibacterial preparations.
Robert PY; Adenis JP
Drugs; 2001; 61(2):175-85. PubMed ID: 11270936
[TBL] [Abstract][Full Text] [Related]
14. Treatment of experimental bacterial keratitis with topical trovafloxacin.
Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
[TBL] [Abstract][Full Text] [Related]
15. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
Segreti J; Jones RN; Bertino JS
J Ocul Pharmacol Ther; 2012 Feb; 28(1):3-11. PubMed ID: 21999341
[TBL] [Abstract][Full Text] [Related]
16. Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
Tu EY; Jain S
Am J Ophthalmol; 2013 Jun; 155(6):1095-1098.e1. PubMed ID: 23453280
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial agents in infections of the central nervous system and eye.
Papastamelos AG; Tunkel AR
Infect Dis Clin North Am; 1995 Sep; 9(3):615-37. PubMed ID: 7490436
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic resistance in ocular bacterial pathogens.
Sharma S
Indian J Med Microbiol; 2011; 29(3):218-22. PubMed ID: 21860100
[TBL] [Abstract][Full Text] [Related]
20. [A review of safety and efficacy of levofloxacin 0.5% ophthalmic solution in the treatment of external ocular infections and in prophylaxis of postoperative endophthalmitis].
Lazicka-Gałecka M; Gałecki T; Szaflik JP
Klin Oczna; 2015; 117(2):123-9. PubMed ID: 26638552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
